We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Hydrogel “Homing Beacon” Recruits Drugs to Tumor Target

News   Jun 13, 2019 | Original story from ACS

 
 Hydrogel “Homing Beacon” Recruits Drugs to Tumor Target

In mice, a hydrogel recruits a dye-labeled molecule (colored areas) to its location, showing its potential for being a “homing beacon” for cancer drugs. Credit: Adapted from ACS Central Science 2019, DOI: 10.1021/acscentsci.9b00195

 
 
Advertisement
 

RELATED ARTICLES

Ancient DNA Elements Can Activate a Powerful Immune Response to Cancer Cells

News

Ancient embedded elements in our DNA from generations past can activate a powerful immune response to kill cancer cells like an infection.

READ MORE

AI Platform Matches Tumor to Most Effective Drug Combo

News

Only 4 percent of all cancer therapeutic drugs under development earn final approval by the U.S. Food and Drug Administration (FDA). Ideker and Brent Kuenzi, PhD, and Jisoo Park, PhD, postdoctoral researchers in his lab, describe DrugCell, a new artificial intelligence (AI) system they created that not only matches tumors to the best drug combinations, but does so in a way that makes sense to humans.

READ MORE

Developing a New Staging System for Prostate Cancer

News

Researchers are developing and validating a novel staging system to better predict outcomes and inform treatment decisions for men diagnosed with non-metastatic prostate cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE